#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glioblastoma multiforme Oesophageal squamous cell carcinoma stage II Central nervous system neoplasm Barth syndrome Intracranial germ cell tumour Meningococcal immunisation White matter lesion Keratosis follicular Angiosarcoma Leiomyosarcoma Ovarian cancer Hereditary angioedema Mastocytosis Alexander disease Adult T-cell lymphoma/leukaemia refractory More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Treatment Anaplastic thyroid cancer – Life with Disease Sarcoidosis – Life with Disease Alport’s syndrome – Diagnostics Hereditary hypophosphataemic rickets – Life with Disease Skin angiosarcoma – Treatment Noonan syndrome – Life with Disease Medulloblastoma – Basic Information Optic glioma – Trials in Disease Carcinoid syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000008866 Lerodalcibep IM-101 Fludeoxyglucose (18F) Nitrogen Furosemide Febuxostat Sodium Iodide (131I) YOHIMBINE HYDROCHLORIDE Falbikitug Cefotaxime Sodium Vincristine INSULIN DEGLUDEC Oxytocin Synthetic Capivasertib Hu5F9‐G4 Retinol Acetate Glutenin Basimglurant LTG-001 More therapies…

    Learn about Your Condition

    Eye pain Thyroid disorder Alpha-1 antitrypsin deficiency Tertiary adrenal insufficiency Hypomagnesaemia Hepatic neoplasm Deep vein thrombosis Hand dermatitis Indolent systemic mastocytosis Obsessive-compulsive disorder Oesophageal food impaction Pharyngeal cancer stage II Endocrine ophthalmopathy Genital herpes Actinic keratosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic kidney disease

  • Study on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Finerenone
    • Semaglutide
    Denmark Germany Italy Spain Sweden

  • Study on Ketoanalogue Supplementation for Muscle Protection in Patients with Stage 4 and 5 Chronic Kidney Disease on a Low Protein Diet

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Alpha-Ketophenylalanine Calcium
    • Hydroxi-Methionine Calcium
    • Keto-Isoleucine Calcium
    France

  • Study on the Safety of Eight Treg and Drug Combination for Patients with Chronic Kidney Failure Undergoing Transplant from a Living Donor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal transplant
    • Chronic kidney disease
    Investigated Drugs:
    • Eight Treg
    • Mycophenolic Acid
    • Cetirizine Dihydrochloride
    France

  • Study on Managing Heart Failure and Kidney Disease in Elderly Patients with High Potassium Risk Using Sodium Zirconium Cyclosilicate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Spain

  • Study of sodium zirconium cyclosilicate compared to standard care for managing high blood potassium levels in patients with chronic kidney disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperkalaemia
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Spain

  • Study on the Effects of Finerenone and SGLT2 Inhibitors on Heart and Kidney Health in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Denmark
Previous Page
1 2 3 4 5 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!